Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Pasmant

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
JCO Precision Oncology|June 7, 2024
Efficacy and Safety of Immune Checkpoint Blockade in Patients With Li-Fraumeni SyndromeMichele Bottosso, Benjamin Verret, Olivier Caron, et al.
British Journal of Cancer|May 13, 2016
Prognostic value of a newly identified MALAT1 alternatively spliced transcript in breast cancerDidier Meseure, Sophie Vacher, François Lallemand, et al.
Journal of Medical Genetics|October 25, 2018
Chemoresistant pleomorphic rhabdomyosarcoma: whole exome sequencing reveals underlying cancer predisposition and therapeutic optionsCamille Tlemsani, Karen Leroy, Anne-Paule Gimenez-Roqueplo, et al.
Blood Cells, Molecules & Diseases|November 9, 2021
Malignant histiocytosis with a Langerhans cell subtype: A report on the diagnostic and therapeutic challengeAmel Kime, Claire Bréal, Anne-Ségolène Cottereau, et al.
Human Mutation|August 6, 2013
NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experienceAudrey Sabbagh, Eric Pasmant, Apolline Imbard, et al.
Familial Cancer|May 19, 2024
A de novo germline pathogenic BRCA1 variant identified following an osteosarcoma pangenomic molecular analysisAdrien Mouren, Albain Chansavang, Nadim Hamzaoui, et al.
Journal of Neuropathology and Experimental Neurology|December 17, 2009
Differential expression of CCN1/CYR61, CCN3/NOV, CCN4/WISP1, and CCN5/WISP2 in neurofibromatosis type 1 tumorigenesisEric Pasmant, Nicolas Ortonne, Laure Rittié, et al.
Human Mutation|March 15, 2019
Proposition of adjustments to the ACMG-AMP framework for the interpretation of MEN1 missense variantsPauline Romanet, Marie-Françoise Odou, Marie-Odile North, et al.
The Journal of Clinical Endocrinology and Metabolism|October 20, 2018
UMD-MEN1 Database: An Overview of the 370 MEN1 Variants Present in 1676 Patients From the French PopulationPauline Romanet, Amira Mohamed, Sophie Giraud, et al.
Human Molecular Genetics|September 11, 2012
Somatic NF1 inactivation is a frequent event in sporadic pheochromocytomaNelly Burnichon, Alexandre Buffet, Béatrice Parfait, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
JCO Precision Oncology|June 7, 2024
Efficacy and Safety of Immune Checkpoint Blockade in Patients With Li-Fraumeni SyndromeMichele Bottosso, Benjamin Verret, Olivier Caron, et al.
British Journal of Cancer|May 13, 2016
Prognostic value of a newly identified MALAT1 alternatively spliced transcript in breast cancerDidier Meseure, Sophie Vacher, François Lallemand, et al.
Journal of Medical Genetics|October 25, 2018
Chemoresistant pleomorphic rhabdomyosarcoma: whole exome sequencing reveals underlying cancer predisposition and therapeutic optionsCamille Tlemsani, Karen Leroy, Anne-Paule Gimenez-Roqueplo, et al.
Blood Cells, Molecules & Diseases|November 9, 2021
Malignant histiocytosis with a Langerhans cell subtype: A report on the diagnostic and therapeutic challengeAmel Kime, Claire Bréal, Anne-Ségolène Cottereau, et al.
Human Mutation|August 6, 2013
NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experienceAudrey Sabbagh, Eric Pasmant, Apolline Imbard, et al.
Familial Cancer|May 19, 2024
A de novo germline pathogenic BRCA1 variant identified following an osteosarcoma pangenomic molecular analysisAdrien Mouren, Albain Chansavang, Nadim Hamzaoui, et al.
Journal of Neuropathology and Experimental Neurology|December 17, 2009
Differential expression of CCN1/CYR61, CCN3/NOV, CCN4/WISP1, and CCN5/WISP2 in neurofibromatosis type 1 tumorigenesisEric Pasmant, Nicolas Ortonne, Laure Rittié, et al.
Human Mutation|March 15, 2019
Proposition of adjustments to the ACMG-AMP framework for the interpretation of MEN1 missense variantsPauline Romanet, Marie-Françoise Odou, Marie-Odile North, et al.
The Journal of Clinical Endocrinology and Metabolism|October 20, 2018
UMD-MEN1 Database: An Overview of the 370 MEN1 Variants Present in 1676 Patients From the French PopulationPauline Romanet, Amira Mohamed, Sophie Giraud, et al.
Human Molecular Genetics|September 11, 2012
Somatic NF1 inactivation is a frequent event in sporadic pheochromocytomaNelly Burnichon, Alexandre Buffet, Béatrice Parfait, et al.
Pageof 13